Objective. —To study the clinical characteristics of respiratory tract illness caused
byChlamydia pneumoniae. Design. —Prospective clinical, bacteriologic, and serologic study. …

Background. Patient engagement throughout research is a way to generate more relevant
patient-important research questions, methods and results with the ultimate aim of facilitating …

… Hahn DL: Chlamydia pneumoniae, asthma and COPD: what is the evidence? Ann
Allergy Asthma Immunol 83, 271-292 (1999) … Hahn DL: Role of Chlamydia pneumoniae …

Asthma is a chronic respiratory disease characterized by reversible airway obstruction and
airway hyperresponsiveness to non-specific bronchoconstriction agonists as the primary …

Background: Macrolides have antimicrobial and anti-inflammatory properties that may be
useful in the treatment of chronic asthma. Methods: We performed a randomized, placebo-…

BACKGROUND: Chlamydia pneumoniae infection can cause acute respiratory illnesses (including
sinusitis, bronchitis, and pneumonia) that are sometimes associated with wheezing. …

Objectives The respiratory pathogen Chlamydia pneumoniae (C. pneumoniae) produces
acute and chronic lung infections and is associated with asthma. Evidence for effectiveness of …

LEARNING OBJECTIVES: Reading this article will familiarize the reader with (1) the unique
chlamydial intracellular life cycle and the propensity for human chlamydial infections to …

Background Several Chlamydia pneumoniae (Cp) biomarkers have been associated with
asthma but Cp-specific IgE (Cp IgE) has not been investigated extensively. Our objective was …

… Requests for reprints should be addressed to David L. Hahn, Arcand Park Clinic, 3434
East … Ordinal regression was used to analyze associations of COPD (l=none, 2=mild, 3=moderate …